 | • レポートコード：MR2211MG12576 • 出版社/出版日：Market Monitor Global / 2022年11月 • レポート形態：英文、PDF、119ページ • 納品方法：Eメール（納期：2-3日） • 産業分類：製薬・ヘルスケア |
| Single User | ￥481,000 (USD3,250) | ▷ お問い合わせ |
| Enterprise User | ￥625,300 (USD4,225) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査資料は次の情報を含め、止血剤＆組織シーラントのグローバル市場規模と予測を記載しています。・止血剤＆組織シーラントのグローバル市場：売上、2017年-2022年、2023年-2028年 ・止血剤＆組織シーラントのグローバル市場：販売量、2017年-2022年、2023年-2028年 ・世界のトップ5企業、2021年 止血剤＆組織シーラントのグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000％のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「止血剤」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。 止血剤＆組織シーラントのグローバル主要企業は、Johnson & Johnson、 Baxter、 C R Bard、 B Braun、 Gelita、 Integra Life Sciences、 Advance Medical Solution、 Pfizer、 CSL Behring、 CryoLife、 Zimmer Biomet、 Ferrosan Medical Devices、 Medtronic、 Smith & Nephew、 Z-Medica、 Cohera Medical、 Marine Polymer、 Equimedicalなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。 マーケットモニターグローバル（MMG）社は、止血剤＆組織シーラントのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。 【セグメント別市場分析】 世界の止血剤＆組織シーラント市場：タイプ別、2017年-2022年、2023年-2028年 世界の止血剤＆組織シーラント市場：タイプ別市場シェア、2021年 ・止血剤、組織封鎖剤 世界の止血剤＆組織シーラント市場：用途別、2017年-2022年、2023年-2028年 世界の止血剤＆組織シーラント市場：用途別市場シェア、2021年 ・低侵襲手術、一般外科、その他 世界の止血剤＆組織シーラント市場：地域・国別、2017年-2022年、2023年-2028年 世界の止血剤＆組織シーラント市場：地域別市場シェア、2021年 ・北米：アメリカ、カナダ、メキシコ ・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア ・アジア：中国、日本、韓国、東南アジア、インド ・南米：ブラジル、アルゼンチン ・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE 【競合分析】 また、当レポートは主要な市場参加者の分析を提供します。 ・主要企業における止血剤＆組織シーラントのグローバル売上、2017年-2022年 ・主要企業における止血剤＆組織シーラントのグローバル売上シェア、2021年 ・主要企業における止血剤＆組織シーラントのグローバル販売量、2017年-2022年 ・主要企業における止血剤＆組織シーラントのグローバル販売量シェア、2021年 さらに、当レポートは主要企業のプロファイルを提示します。 Johnson & Johnson、 Baxter、 C R Bard、 B Braun、 Gelita、 Integra Life Sciences、 Advance Medical Solution、 Pfizer、 CSL Behring、 CryoLife、 Zimmer Biomet、 Ferrosan Medical Devices、 Medtronic、 Smith & Nephew、 Z-Medica、 Cohera Medical、 Marine Polymer、 Equimedical ************************************************************* ・調査・分析レポートの概要 止血剤＆組織シーラント市場の定義 市場セグメント 世界の止血剤＆組織シーラント市場概要 当レポートの特徴・ベネフィット 調査手法と情報源 ・世界の止血剤＆組織シーラント市場規模 世界の止血剤＆組織シーラント市場規模：2021年 VS 2028年 世界の止血剤＆組織シーラント市場規模と予測 2017年-2028年 ・競争状況 グローバルトップ企業 売上ベースでのグローバルトップ企業 企業別グローバルでの止血剤＆組織シーラントの売上 グローバルトップ3およびトップ5企業、2021年売上ベース グローバル企業の止血剤＆組織シーラント製品タイプ グローバルにおけるティア1、ティア2、ティア3企業 ・タイプ別市場分析 タイプ区分：止血剤、組織封鎖剤 止血剤＆組織シーラントのタイプ別グローバル売上・予測 ・用途別市場分析 用途区分：低侵襲手術、一般外科、その他 止血剤＆組織シーラントの用途別グローバル売上・予測 ・地域別市場分析 地域別止血剤＆組織シーラント市場規模 2021年と2028年 地域別止血剤＆組織シーラント売上・予測 北米市場 - アメリカの止血剤＆組織シーラント市場規模2017年-2028年 - カナダの止血剤＆組織シーラント市場規模2017年-2028年 - メキシコの止血剤＆組織シーラント市場規模2017年-2028年 ヨーロッパ市場 - ドイツの止血剤＆組織シーラント市場規模2017年-2028年 - フランスの止血剤＆組織シーラント市場規模2017年-2028年 - イギリスの止血剤＆組織シーラント市場規模2017年-2028年 - イタリアの止血剤＆組織シーラント市場規模2017年-2028年 - ロシアの止血剤＆組織シーラント市場規模2017年-2028年 アジア市場 - 中国の止血剤＆組織シーラント市場規模2017年-2028年 - 日本の止血剤＆組織シーラント市場規模2017年-2028年 - 韓国の止血剤＆組織シーラント市場規模2017年-2028年 - 東南アジアの止血剤＆組織シーラント市場規模2017年-2028年 - インドの止血剤＆組織シーラント市場規模2017年-2028年 南米市場 - ブラジルの止血剤＆組織シーラント市場規模2017年-2028年 - アルゼンチンの止血剤＆組織シーラント市場規模2017年-2028年 中東・アフリカ市場 - トルコの止血剤＆組織シーラント市場規模2017年-2028年 - イスラエルの止血剤＆組織シーラント市場規模2017年-2028年 - サウジアラビアの止血剤＆組織シーラント市場規模2017年-2028年 - UAEの止血剤＆組織シーラント市場規模2017年-2028年 ・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど） Johnson & Johnson、 Baxter、 C R Bard、 B Braun、 Gelita、 Integra Life Sciences、 Advance Medical Solution、 Pfizer、 CSL Behring、 CryoLife、 Zimmer Biomet、 Ferrosan Medical Devices、 Medtronic、 Smith & Nephew、 Z-Medica、 Cohera Medical、 Marine Polymer、 Equimedical ... |
Hemostats and sealants are medical devices used to cease bleeding and hemorrhage caused by injuries and surgical procedures. The market is expected to witness lucrative growth over the next seven years owing to an increase in demand supported by the rising surgery volumes.
This report contains market size and forecasts of Hemostatic Agents and Tissue Sealants in global, including the following market information:
Global Hemostatic Agents and Tissue Sealants Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Hemostatic Agents and Tissue Sealants Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Hemostatic Agents and Tissue Sealants companies in 2021 (%)
The global Hemostatic Agents and Tissue Sealants market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Hemostasis Agents Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Hemostatic Agents and Tissue Sealants include Johnson & Johnson, Baxter, C R Bard, B Braun, Gelita, Integra Life Sciences, Advance Medical Solution, Pfizer and CSL Behring, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Hemostatic Agents and Tissue Sealants manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Hemostatic Agents and Tissue Sealants Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemostatic Agents and Tissue Sealants Market Segment Percentages, by Type, 2021 (%)
Hemostasis Agents
Tissue Sealing Agents
Global Hemostatic Agents and Tissue Sealants Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemostatic Agents and Tissue Sealants Market Segment Percentages, by Application, 2021 (%)
Minimally Invasive Surgery
General Surgery
Others
Global Hemostatic Agents and Tissue Sealants Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Hemostatic Agents and Tissue Sealants Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Hemostatic Agents and Tissue Sealants revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Hemostatic Agents and Tissue Sealants revenues share in global market, 2021 (%)
Key companies Hemostatic Agents and Tissue Sealants sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Hemostatic Agents and Tissue Sealants sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Johnson & Johnson
Baxter
C R Bard
B Braun
Gelita
Integra Life Sciences
Advance Medical Solution
Pfizer
CSL Behring
CryoLife
Zimmer Biomet
Ferrosan Medical Devices
Medtronic
Smith & Nephew
Z-Medica
Cohera Medical
Marine Polymer
Equimedical
1 Introduction to Research & Analysis Reports
1.1 Hemostatic Agents and Tissue Sealants Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Hemostatic Agents and Tissue Sealants Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Hemostatic Agents and Tissue Sealants Overall Market Size
2.1 Global Hemostatic Agents and Tissue Sealants Market Size: 2021 VS 2028
2.2 Global Hemostatic Agents and Tissue Sealants Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Hemostatic Agents and Tissue Sealants Sales: 2017-2028
3 Company Landscape
3.1 Top Hemostatic Agents and Tissue Sealants Players in Global Market
3.2 Top Global Hemostatic Agents and Tissue Sealants Companies Ranked by Revenue
3.3 Global Hemostatic Agents and Tissue Sealants Revenue by Companies
3.4 Global Hemostatic Agents and Tissue Sealants Sales by Companies
3.5 Global Hemostatic Agents and Tissue Sealants Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Hemostatic Agents and Tissue Sealants Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Hemostatic Agents and Tissue Sealants Product Type
3.8 Tier 1, Tier 2 and Tier 3 Hemostatic Agents and Tissue Sealants Players in Global Market
3.8.1 List of Global Tier 1 Hemostatic Agents and Tissue Sealants Companies
3.8.2 List of Global Tier 2 and Tier 3 Hemostatic Agents and Tissue Sealants Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Hemostatic Agents and Tissue Sealants Market Size Markets, 2021 & 2028
4.1.2 Hemostasis Agents
4.1.3 Tissue Sealing Agents
4.2 By Type – Global Hemostatic Agents and Tissue Sealants Revenue & Forecasts
4.2.1 By Type – Global Hemostatic Agents and Tissue Sealants Revenue, 2017-2022
4.2.2 By Type – Global Hemostatic Agents and Tissue Sealants Revenue, 2023-2028
4.2.3 By Type – Global Hemostatic Agents and Tissue Sealants Revenue Market Share, 2017-2028
4.3 By Type – Global Hemostatic Agents and Tissue Sealants Sales & Forecasts
4.3.1 By Type – Global Hemostatic Agents and Tissue Sealants Sales, 2017-2022
4.3.2 By Type – Global Hemostatic Agents and Tissue Sealants Sales, 2023-2028
4.3.3 By Type – Global Hemostatic Agents and Tissue Sealants Sales Market Share, 2017-2028
4.4 By Type – Global Hemostatic Agents and Tissue Sealants Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application – Global Hemostatic Agents and Tissue Sealants Market Size, 2021 & 2028
5.1.2 Minimally Invasive Surgery
5.1.3 General Surgery
5.1.4 Others
5.2 By Application – Global Hemostatic Agents and Tissue Sealants Revenue & Forecasts
5.2.1 By Application – Global Hemostatic Agents and Tissue Sealants Revenue, 2017-2022
5.2.2 By Application – Global Hemostatic Agents and Tissue Sealants Revenue, 2023-2028
5.2.3 By Application – Global Hemostatic Agents and Tissue Sealants Revenue Market Share, 2017-2028
5.3 By Application – Global Hemostatic Agents and Tissue Sealants Sales & Forecasts
5.3.1 By Application – Global Hemostatic Agents and Tissue Sealants Sales, 2017-2022
5.3.2 By Application – Global Hemostatic Agents and Tissue Sealants Sales, 2023-2028
5.3.3 By Application – Global Hemostatic Agents and Tissue Sealants Sales Market Share, 2017-2028
5.4 By Application – Global Hemostatic Agents and Tissue Sealants Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region – Global Hemostatic Agents and Tissue Sealants Market Size, 2021 & 2028
6.2 By Region – Global Hemostatic Agents and Tissue Sealants Revenue & Forecasts
6.2.1 By Region – Global Hemostatic Agents and Tissue Sealants Revenue, 2017-2022
6.2.2 By Region – Global Hemostatic Agents and Tissue Sealants Revenue, 2023-2028
6.2.3 By Region – Global Hemostatic Agents and Tissue Sealants Revenue Market Share, 2017-2028
6.3 By Region – Global Hemostatic Agents and Tissue Sealants Sales & Forecasts
6.3.1 By Region – Global Hemostatic Agents and Tissue Sealants Sales, 2017-2022
6.3.2 By Region – Global Hemostatic Agents and Tissue Sealants Sales, 2023-2028
6.3.3 By Region – Global Hemostatic Agents and Tissue Sealants Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country – North America Hemostatic Agents and Tissue Sealants Revenue, 2017-2028
6.4.2 By Country – North America Hemostatic Agents and Tissue Sealants Sales, 2017-2028
6.4.3 US Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.4.4 Canada Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.4.5 Mexico Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.5 Europe
6.5.1 By Country – Europe Hemostatic Agents and Tissue Sealants Revenue, 2017-2028
6.5.2 By Country – Europe Hemostatic Agents and Tissue Sealants Sales, 2017-2028
6.5.3 Germany Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.5.4 France Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.5.5 U.K. Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.5.6 Italy Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.5.7 Russia Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.5.8 Nordic Countries Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.5.9 Benelux Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.6 Asia
6.6.1 By Region – Asia Hemostatic Agents and Tissue Sealants Revenue, 2017-2028
6.6.2 By Region – Asia Hemostatic Agents and Tissue Sealants Sales, 2017-2028
6.6.3 China Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.6.4 Japan Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.6.5 South Korea Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.6.6 Southeast Asia Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.6.7 India Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.7 South America
6.7.1 By Country – South America Hemostatic Agents and Tissue Sealants Revenue, 2017-2028
6.7.2 By Country – South America Hemostatic Agents and Tissue Sealants Sales, 2017-2028
6.7.3 Brazil Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.7.4 Argentina Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Hemostatic Agents and Tissue Sealants Revenue, 2017-2028
6.8.2 By Country – Middle East & Africa Hemostatic Agents and Tissue Sealants Sales, 2017-2028
6.8.3 Turkey Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.8.4 Israel Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.8.5 Saudi Arabia Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
6.8.6 UAE Hemostatic Agents and Tissue Sealants Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Johnson & Johnson
7.1.1 Johnson & Johnson Corporate Summary
7.1.2 Johnson & Johnson Business Overview
7.1.3 Johnson & Johnson Hemostatic Agents and Tissue Sealants Major Product Offerings
7.1.4 Johnson & Johnson Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.1.5 Johnson & Johnson Key News
7.2 Baxter
7.2.1 Baxter Corporate Summary
7.2.2 Baxter Business Overview
7.2.3 Baxter Hemostatic Agents and Tissue Sealants Major Product Offerings
7.2.4 Baxter Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.2.5 Baxter Key News
7.3 C R Bard
7.3.1 C R Bard Corporate Summary
7.3.2 C R Bard Business Overview
7.3.3 C R Bard Hemostatic Agents and Tissue Sealants Major Product Offerings
7.3.4 C R Bard Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.3.5 C R Bard Key News
7.4 B Braun
7.4.1 B Braun Corporate Summary
7.4.2 B Braun Business Overview
7.4.3 B Braun Hemostatic Agents and Tissue Sealants Major Product Offerings
7.4.4 B Braun Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.4.5 B Braun Key News
7.5 Gelita
7.5.1 Gelita Corporate Summary
7.5.2 Gelita Business Overview
7.5.3 Gelita Hemostatic Agents and Tissue Sealants Major Product Offerings
7.5.4 Gelita Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.5.5 Gelita Key News
7.6 Integra Life Sciences
7.6.1 Integra Life Sciences Corporate Summary
7.6.2 Integra Life Sciences Business Overview
7.6.3 Integra Life Sciences Hemostatic Agents and Tissue Sealants Major Product Offerings
7.6.4 Integra Life Sciences Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.6.5 Integra Life Sciences Key News
7.7 Advance Medical Solution
7.7.1 Advance Medical Solution Corporate Summary
7.7.2 Advance Medical Solution Business Overview
7.7.3 Advance Medical Solution Hemostatic Agents and Tissue Sealants Major Product Offerings
7.7.4 Advance Medical Solution Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.7.5 Advance Medical Solution Key News
7.8 Pfizer
7.8.1 Pfizer Corporate Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Hemostatic Agents and Tissue Sealants Major Product Offerings
7.8.4 Pfizer Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.8.5 Pfizer Key News
7.9 CSL Behring
7.9.1 CSL Behring Corporate Summary
7.9.2 CSL Behring Business Overview
7.9.3 CSL Behring Hemostatic Agents and Tissue Sealants Major Product Offerings
7.9.4 CSL Behring Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.9.5 CSL Behring Key News
7.10 CryoLife
7.10.1 CryoLife Corporate Summary
7.10.2 CryoLife Business Overview
7.10.3 CryoLife Hemostatic Agents and Tissue Sealants Major Product Offerings
7.10.4 CryoLife Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.10.5 CryoLife Key News
7.11 Zimmer Biomet
7.11.1 Zimmer Biomet Corporate Summary
7.11.2 Zimmer Biomet Hemostatic Agents and Tissue Sealants Business Overview
7.11.3 Zimmer Biomet Hemostatic Agents and Tissue Sealants Major Product Offerings
7.11.4 Zimmer Biomet Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.11.5 Zimmer Biomet Key News
7.12 Ferrosan Medical Devices
7.12.1 Ferrosan Medical Devices Corporate Summary
7.12.2 Ferrosan Medical Devices Hemostatic Agents and Tissue Sealants Business Overview
7.12.3 Ferrosan Medical Devices Hemostatic Agents and Tissue Sealants Major Product Offerings
7.12.4 Ferrosan Medical Devices Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.12.5 Ferrosan Medical Devices Key News
7.13 Medtronic
7.13.1 Medtronic Corporate Summary
7.13.2 Medtronic Hemostatic Agents and Tissue Sealants Business Overview
7.13.3 Medtronic Hemostatic Agents and Tissue Sealants Major Product Offerings
7.13.4 Medtronic Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.13.5 Medtronic Key News
7.14 Smith & Nephew
7.14.1 Smith & Nephew Corporate Summary
7.14.2 Smith & Nephew Business Overview
7.14.3 Smith & Nephew Hemostatic Agents and Tissue Sealants Major Product Offerings
7.14.4 Smith & Nephew Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.14.5 Smith & Nephew Key News
7.15 Z-Medica
7.15.1 Z-Medica Corporate Summary
7.15.2 Z-Medica Business Overview
7.15.3 Z-Medica Hemostatic Agents and Tissue Sealants Major Product Offerings
7.15.4 Z-Medica Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.15.5 Z-Medica Key News
7.16 Cohera Medical
7.16.1 Cohera Medical Corporate Summary
7.16.2 Cohera Medical Business Overview
7.16.3 Cohera Medical Hemostatic Agents and Tissue Sealants Major Product Offerings
7.16.4 Cohera Medical Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.16.5 Cohera Medical Key News
7.17 Marine Polymer
7.17.1 Marine Polymer Corporate Summary
7.17.2 Marine Polymer Business Overview
7.17.3 Marine Polymer Hemostatic Agents and Tissue Sealants Major Product Offerings
7.17.4 Marine Polymer Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.17.5 Marine Polymer Key News
7.18 Equimedical
7.18.1 Equimedical Corporate Summary
7.18.2 Equimedical Business Overview
7.18.3 Equimedical Hemostatic Agents and Tissue Sealants Major Product Offerings
7.18.4 Equimedical Hemostatic Agents and Tissue Sealants Sales and Revenue in Global (2017-2022)
7.18.5 Equimedical Key News
8 Global Hemostatic Agents and Tissue Sealants Production Capacity, Analysis
8.1 Global Hemostatic Agents and Tissue Sealants Production Capacity, 2017-2028
8.2 Hemostatic Agents and Tissue Sealants Production Capacity of Key Manufacturers in Global Market
8.3 Global Hemostatic Agents and Tissue Sealants Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Hemostatic Agents and Tissue Sealants Supply Chain Analysis
10.1 Hemostatic Agents and Tissue Sealants Industry Value Chain
10.2 Hemostatic Agents and Tissue Sealants Upstream Market
10.3 Hemostatic Agents and Tissue Sealants Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Hemostatic Agents and Tissue Sealants Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer